Cytosorbents CorporationCTSONASDAQ
Loading
R&D Expense Growth Under PressureDecelerating
Percentile Rank0
Studio
Year-over-Year Change

Year-over-year research & development expense growth

Percentile
P0
Near historical low
vs 5Y Ago
-1x
Contraction
Streak
1 yr
Consecutive declineDecelerating
PeriodValue
2024-55.65%
20233.15%
2022-7.70%
202185.92%
2020-27.14%
201956.57%
201890.72%
2017-15.35%
201623.57%
201559.17%